Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Indices News Spotlights Stocks

Stock Market Today: Dow snaps 4-day win streak on mixed economic data

post-img

The Dow closed lower Thursday, snapping a four-day wining streak as investors weighed up mixed economic showing steady inflation, but still-strong consumer spending ahead of the crucial monthly jobs report due Friday.

The Dow Jones Industrial Average fell 0.5%, 169 points, Nasdaq gained 0.1%, the S&P 500 fell 0.2%.

Fed pause hopes still alive amid in-line Inflation, hot consumer spending data
The core personal consumption expenditures price index, the Fed’s preferred gauge of inflation, rose 0.2% in July, in-line with the prior month’s pace and economists’ expectations.

But consumer spending, rose 0.8% in July, the fastest pace in more than six months, “perpetuating the notion of a resilient consumer,” Stifel said in a note.

Despite the strong consumer data and still-above trend inflation, just 12% of traders expect the Fed to deliver its twelfth rate-hike on Sept. 20, Stifel added, with about 56% of investors anticipate another hold.

Salesforce, Crowdstrike win big on earnings stage
Salesforce Inc (NYSE:CRM) lifted its guidance after reporting second-quarter results that topped Wall Street estimates, driven by momentum in MuleSoft, — the firm’s integration software used to connect applications and data – while its “overall subscription business further proving strength in the Beltway,” Wedbush said in a note.

Crowdstrike Holdings Inc (NASDAQ:CRWD) also reported a beat and raise in the quarter, underpinned by improved margins in the quarter amid ongoing cybersecurity demand.

After clearing the tough second-quarter bar, Crowdstrike “will now lap significantly easier comps as cloud security, identity threat detection, and LogScale/Observability all hit respective strides,” UBS said, adding that it likes the setup for the company into the second half of the year.

Dollar General punished for annual guidance cut, underwhelming quarterly results
Dollar General Corporation (NYSE:DG) fell 12% as the discount retailer cut its full-year guidance after quarterly earnings missed Wall Street estimates amid weaker consumer demand and inventory shrink, a loss in inventory not due to sales but other factors including employee theft.

Gross margin fell 126 basis points, “primarily driven by lower markups, increased shrink, markdowns, inventory damages, and unfavorable category mix shift, partially offset by a lower LIFO provision and a reduction in transportation costs,” Goldman Sachs said in a note.

Cannabis stocks on fire amid easing restrictions
Cannabis stocks including Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (TSX:ACB), and Tilray Inc (NASDAQ:TLRY), with latter up more than 12%, surged on optimism the U.S. government may reclassify marijuana to a much lower risk category.

The U.S. Department of Health and Human Services delivered a recommendation to the U.S. Drug Enforcement Administration that marijuana be moved from its current Schedule I to Schedule III of the Controlled Substances Act.

“While the recommendation has yet to be confirmed by the DEA, we view this as a positive development, which materially increase the odds of a rescheduling to Schedule III, which as mentioned would be a boon for the industry,” Wedbush said in a recent note.

Related Post